Important: Therapy notes
Important: Formulation and dosage details
Formulation:
Solution for subcutaneous injection 120mg/mL (specialist use only)
Dosage:
See SMC advice 33/03, 135/04, 330/06, 591/09, 675/11, 975/14 and NICE guidance TA137, TA065. Also for selected patients with CD 20+ B-cell lymphomas/lymphoproliferative and haematological autoimmune disorders off-label.